|
|
|
|
|
|
|
|
MBS8208837-15nmol
|
MyBiosource |
|
15nmol |
|
|
|
MBS8208837-30nmol
|
MyBiosource |
|
30nmol |
|
|
|
MBS8208837-5x30nmol
|
MyBiosource |
|
5x30nmol |
|
|
|
MBS8241131-15nmol
|
MyBiosource |
|
15nmol |
|
|
|
MBS8241131-30nmol
|
MyBiosource |
|
30nmol |
|
|
|
MBS8241131-5x30nmol
|
MyBiosource |
|
5x30nmol |
|
|
|
MBS829241-15nmol
|
MyBiosource |
|
15nmol |
|
|
|
MBS829241-30nmol
|
MyBiosource |
|
30nmol |
|
|
|
MBS829241-5x30nmol
|
MyBiosource |
|
5x30nmol |
|
|
|
SR302604
|
Origene Technologies GmbH |
|
2 nmol |
|
|
|
SR419364
|
Origene Technologies GmbH |
|
2 nmol |
|
|
|
CSB-CL012535HU
|
Cusabio |
|
10 μg plasmid + 200μl Glycerol |
|
|
|
MBS8563526-01mLAF405L
|
MyBiosource |
|
0.1mL(AF405L) |
|
|
|
MBS8563526-01mLAF405S
|
MyBiosource |
|
0.1mL(AF405S) |
|
|
|
MBS8563526-01mLAF610
|
MyBiosource |
|
0.1mL(AF610) |
|
|
|
MBS8563526-01mLAF635
|
MyBiosource |
|
0.1mL(AF635) |
|
|
|
MBS8563526-02mL
|
MyBiosource |
|
0.2mL |
|
|
|
MBS8535357-01mL
|
MyBiosource |
|
0.1mL |
|
|
|
MBS8535357-01mLAF405L
|
MyBiosource |
|
0.1mL(AF405L) |
|
|
|
MBS8535357-01mLAF405S
|
MyBiosource |
|
0.1mL(AF405S) |
|
|
|
MBS8535357-01mLAF610
|
MyBiosource |
|
0.1mL(AF610) |
|
|
|
MBS8535357-01mLAF635
|
MyBiosource |
|
0.1mL(AF635) |
|
|
|
SC300067
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
RG213030
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
MC220732
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
|
|
|
|
E035627
|
EnoGene |
|
100μg/100μl |
|
|
|
|
|
|
|
|
|
|
|
K06323M03C05C-100ug
|
Absea Biotechnology |
|
100 ug |
|
|
|
K06323M03C05C-1mg
|
Absea Biotechnology |
|
1 mg |
|
|
|
K06323M03C05C-50ug
|
Absea Biotechnology |
|
50 ug |
|
|
|
MBS7123329-005mL
|
MyBiosource |
|
0.05mL |
|
|
|
MBS7123329-01mL
|
MyBiosource |
|
0.1mL |
|
|
|
MBS7123329-5x01mL
|
MyBiosource |
|
5x0.1mL |
|
|
|
MBS7117556-005mg
|
MyBiosource |
|
0.05mg |
|
|
|
MBS7117556-01mg
|
MyBiosource |
|
0.1mg |
|
|
|
MBS7117556-5x01mg
|
MyBiosource |
|
5x0.1mg |
|
|
|
MBS9411052-01mL
|
MyBiosource |
|
0.1mL |
|
|
|
MBS9411052-5x01mL
|
MyBiosource |
|
5x0.1mL |
|
|
|
|
|
|
|
|
|